The 63rd Annual conference of the Indian Society of Haematology and Blood Transfusion

CME - 3rd NOVEMBER 2022, Thusrday


Hall A

Hall B

Hall C

Hall D

8.00 AM onwards


9.30-10.45 AM

Session 1 - Thrombosis-1

Chairpersons: Dr Nidhi Dixit & Dr. Kaushik Roy

Session 2 - Red Cell Disorders-1

Chairpersons: Dr. Sreeya Das & Dr. S. K. Gupta

Session 3-Laboratory Haematology

Chairperson: Dr. Rajat Mukherjee & Dr. Abhishek Sharma

Session 4-Laboratory Technology

Chairpersons: Dr. Gurmeet Singh & Dr. J.M.Khunger

9.30-9.50 AM

Venous thrombo embolism: Diagnosis

Speaker: Dr. Ashutosh Panigrahi

Complications in NTDT:Management and monitoring

Speaker: Dr. Priyanka Samal

Laboratory monitoring of DOAC.

Speaker: Dr. Dinesh Chandra

HPLC chromatogram interpretation.

Speaker: Dr. Mrinalini Kotru

9.50-10.10 AM

Venous thrombo embolism: Management.

Speaker: Dr. Tusti Ganguly

Cold Agglutinin Disease: Pathophysiology,evaluation and management.

Speaker: Dr. Asif Iqbal

Dry tap in bone marrow: Etiology and approach.

Speaker: Dr. Abhishek Purohit

Diagnosis of platelet function disorders.

Speaker: Dr. Jyoti Bajaj

10.10-10.30 AM

Arterial thrombo embolism from haematologist’s perspective

Speaker: Dr. Pooja Prasad

Erythroid growth factors: Applications and adverse effects.

Speaker: Dr. Ankit Jitani

Approach to IHC in lymphomas.

Speaker: Dr. Tathagata Chatterjee

Scientific considerations in the purchase of automated CBC analysers

Speaker: Dr. Prashant Sharma

10.30-10.45 AM





10.45-11.15 AM


11.15-12.30 PM

Session 5 - Indian College of Haematology

Chairpersons: Dr. Tejindar Singh
Dr. Shanaz Khodaiji
Dr. R K Jena

Session 6 - Lymphoma

Chairpersons: Dr. Narender Kumar & Dr. Sachin Jain

Session 7 - The patient on anticoagulants

Chairpersons: Dr.Subhajit Hazra & Dr. Sreeraj Vasudevan

Session 8 - Advance laboratory technology

Chairpersons: Dr. R.Manchanda & Dr. Bibhas Kar

11.15-11.35 AM

Inaugural Function

Role of FDG-PETCT imaging in lymphoma.

Speaker: Dr. Dibyendu De

Surgery in a patient on anticoagulants.

Speaker: Dr. Abhijit Phukan

Basic requirements of molecular laboratory.

Speaker: Dr. Ekta Jajodia

11.35-11.55 AM

Treatment of myeloma -a roadmap for the next 5 years.

Speaker: Dr. Shaji Kumar

International consensus classification of mature lymphoid of neoplasms (2022): What is new?

Speaker: Dr. Nabhajit Mallik

DKA versus DOAC: Pros and cons.

Speaker: Dr. Amit Khurana

Types of PCR and applications.

Speaker: Dr. Jyoti Shaw

11.55-12.15 PM

Collaboration of ICH & ICMR in Hematological Diseases of Public Health Importance.

Speaker: Dr. Bontha V. Babu

Indolent T cell lymphomas.

Speaker: Dr. Prabu Pandurangan

Anticoagulant antidotes.

Speaker: Dr. Prakash Singh Shekhawat

Cytogenetics studies in haematology:Tools and interpretation.

Speaker: Dr. Anurag Gupta

12.15-12.30 PM

Outreach Program of ICH: Need of the Hour

Speaker: Dr. Jyotirmoy Pal




12.30-1.30 PM

Lunch Break

2.00-3.15 PM

Session 9 - Thrombosis-2

Chairpersons: Dr. Basab Bagchi & Dr. Dibyendu De

Session 10 - Stem Cell Transplant

Chairpersons: Dr. Faheema Hasan & Dr. Siddartha Sankar Ray

Session 11 - Apheresis

Chairpersons: Dr. Abhijit Phukan & Dr. Pawan Kumar Singh

Session 12 - Nursing CME-1

Chairpersons: Dr. Praveen Sharma & Dr. Bhavana Dhingra

2.00-2.20 PM

APLA: Diagnosis and risk management.

Speaker: Dr. Riya Ballikar

Pre transplant work-up.

Speaker: Dr. Jeevan Kumar Garge

Applications of therapeutic apheresis.

Speaker: Dr. Shruti Prem S

Nursing care of the neutropenic patient.

Speaker: Dr. Subham Bhattacharya

2.20-2.40 PM

Thrombophilia test: When and what to do?

Speaker: Dr. Pritish Chandra Patra

Real World Evidence and its application in myeloma practice

Speaker: Dr. Supratik Basu

Apheresis for SDP and granulocytes.

Speaker: Dr. Ritam Chakraborty

Care of the indwelling access device.

Speaker: Dr. Malini Garg

2.40-3.00 PM

POC test in Coagulation.

Speaker: Dr. Jasmita Das

Conditioning regimes used in SCT.

Speaker: Dr. Meet Kumar

Stem cell sources and procurement.

Speaker: Dr. Suvro Datta

Role of the nurse in haematology day care.

Speaker: Dr. Manisha Jain

3.00-3.15 PM





3.15-4.30 PM

Session 13 - Infections in Haematology

Chairpersons: Dr. Tusti Ganguly & Dr. Nandini Chakrabarti

Session 14 - Disorders of bleeding

Chairpersons: Dr. Damodar Das & Dr Kalyan Kusum Mukherjee

Session 15 - MPN

Chairpersons: Dr. Ashok Rajorey & Dr. Nilanjan Sinha

Session 16 - Nursing CME-2

Chairpersons: Dr. Pooja Murgai & Dr. Sarika Singh

3.15-3.35 PM

Infection prophylaxis in haematological setting.

Speaker: Dr. Jasjit Singh

Approach to the patient with excessive bleeding.

Speaker: Dr. Upendra Srinivas

Molecular genetic landscape in MPNs.

Speaker: Dr. Vijai Tilak

Monitoring blood transfusion: Role of the nurse.

Speaker: Dr. Biplabendu Talukder

3.35-3.55 PM

Assessment and management of febrile neutropenia.

Speaker: Dr. Ankur Jain

Acquired haemophilia.

Speaker: Dr. Subhaprakash Sanyal

Systemic mastocytosis: Pathophysiology & clinical features.

Speaker: Dr. Samira K Behera

Nutritional care haematology patient: Role of the nurse.

Speaker: Dr. Saikat Datta

3.55-4.15 PM

DIC: Evaluation & Management.

Speaker: Dr. Alka Khadwal

Bleeding with normal screening coagulogram.

Speaker: Dr. Ankur Ahuja

Systemic mastocytosis: Diagnosis and management.

Speaker: Dr. Javed Rasool Bhatt

Nursing care of the transplant patient.

Speaker: Dr. Avriti Baveja

4.15-4.30 PM





4.30 - 5.40 PM

Session on Industry Symposium

Session on Quality of Hematology service

Chronic Myeloid Leukemia

4.30 - 4.35 PM


04.30 - 04.45 PM : NHA initiatives on Hematological disorders

Speaker :Dr. Shankar Prinja

04.30 - 05.00 PM : Topic : Unmet need in the management of CML in 3rd line & Beyond

Speaker : Dr. Prantar Chakrabarti

4.35 - 4.45 PM

Looking forward

Speaker: Dr. R K Jena

04.45 - 05.00 PM : Niti AAyog-Sickle cell interventions

Speaker :Dr. Bhanu Duggal

4.45 - 5.00 PM

What a Haematologist expect from pharma professionals?

Speaker: Dr. Rahul Bhargava

05.00 - 05.15 PM : MoTA - Sickle cell road map in regard to prevention and management

Speaker :Dr. Vinita Srivastava

5.00 - 5.20 PM

How to make a Career in the Pharmaceutical Industry?

Speaker: Dr. Manoj Kumar

05.15 - 05.30 PM : Blood Transfusion and its Utilisation in Hematological

Speaker :Dr. Subhash

5.20 - 5.40 PM

How the Industry is Changing and How We Should Change Ourselves?

Moderator: Dr. Gopal Rawal

Panelists: Dr. Ashish Kumar,Dr. Santanu Chattopadhyay,Dr. Keyur Soni,Dr. Pushkar Singh

7.30 PM Onwards

Dinner at : Biswa Bangla Convention Center

4thNOVEMBER 2022, Friday


Hall A

Hall B

Hall C

Hall D

7.15 AM onwards


7.45-8.15 AM


8.15-8.45 AM

Session 17 - Dr. J. G. Parekh Oration(Hall A)

Chairperson: Dr. Nabanita Chakraborty & Dr. T. K.Dutta

Topic: Identification of new targets and biomarkers for Multiple Myeloma
using Proteomic and Metabolomics approaches

Speaker - Dr Tathagata Chatterjee

8.45 - 10.00 AM

Session 18 - Haemophilia

Chairpersons: Dr. Santanu Basu & Dr. Gargi Kapatia

Session 19 - Myelofibrosis

Chairpersons: Dr. Mitu Srikhande & Dr. Shailendra Prasad Verma

Session 20 - MRD

Chairpersons: Dr. Richa Juneja & Dr. Sachin Bansal

Session 21 - Mantle Cell Lymphoma

Chairpersons: Dr. Soumya Bhattacharya & Dr. Shilpa Bhartia

8:45 - 9:10 AM

Haemophilia with inhibitors-Diagnosis and pitfalls.

Speaker: Dr. Tulika Seth

Myelofibrosis: assessing prognosis.

Speaker: Dr. M. B. Agarwal

Tools for MRD detection.

Speaker: Dr. Deepak K Mishra

Mantel Cell Lymphoma: Diagnostic issues.

Speaker: Dr. Saumyaranjan Mallick

9:10 -9:35 AM

Changing landscape in Haemophilia prophylaxis.

Speaker: Dr. Philip Kuriakose

Myelofibrosis: Symptom directed management.

Speaker: Dr. Uday Yanamandra

Update on MRD in AML: Are we in a position to decide further therapy?

Speaker: Dr. Ashish Dixit

Frontline management of MCL: Indian Perspective.

Speaker: Dr. Reena Nair

9:35 - 10:00 AM

Haemophilia gene therapy: Optimisms and questions.

Speaker: Dr. Prakas Kumar Mandal

Myelofibrosis: Ruxolitimib and beyond

Speaker: Dr. Manoranjan Mahapatra

MRD in MM: Current status.

Speaker: Dr. K S Nataraj

Role of Novel agents in treatment of MCL.

Speaker: Dr. Priyanka Pophali

10.00-10.25 AM

Session 22

Chairpersons: Dr. Somanath Padhi & Dr. Preeti Tripathi

A Systems Approach to Blood Disorders-an update from National Heart, Lung, and Blood Institute (NHLBI)

Speaker : Dr Pankaj Qasba, Program Director

Session 23

Chairpersons: Dr. D. K. Mishra & Dr. Pushkar Admane

Sherlock Holming in haematology:resurrection of diagnostic morphology

Speaker : Dr. Vishal Jayakar

Session 24

Chairpersons: Dr. Krishna Basu & Dr. Soumitro Ghosh

Topic - Chronic myeloid leukemia: Challenges and ahead

Speaker : Dr. Tusti Ganguly

Session 25

Chairpersons: Dr. Gaurav Chhabra & Dr Sanjay Gohil

Manufacturing of Car T Products –an overview

Speaker : Dr. Rizwan Javed

10.25-10.55 AM

Coffee Break

10.55-12.25 PM

Session 26-ISHBT-ASH Joint Symposium (Hall A)

Topic: Sickle Cell Disease

Chairpersons: Dr. Haraprasad Pati & Dr. Mohandas Narla

Topic: Practical Management and outcome of SCD

Speaker: Dr. Mohandas Narla

Topic: Role of gene therapy in SCD

Speaker: Dr. Alexis A.Thompson

Topic: Sickle cell disease in India - How it different from west?

Speaker: Dr. R. K. Jena

12.25-1.25 PM

Sponsored Symposium-1

By Takeda

Panel discussion: Clinical cases on Hemophilia management: Role of Bleed impact model

12.25- 12.30 PM : Welcome Note & Introduction

12.30- 12.55 PM : Case 1

12.55- 1.20 PM : Case 2

Moderator: Dr. C Ravichandran

Pannelists: Dr Tuphan K Dolai, Dr Prakas Kumar Mandal,Dr Varun Kaul, Dr. Biplabendu Talukdar, Dr Vishnu Sharma

1.20- 1.25 PM : Vote of thanks

Sponsored Symposium-2

By Intas Pharmaceuticals Ltd.

12.25- 12.45 PM : Topic: Fibrinogen

Speaker: Dr. Nita Radhakrishnan

12.45- 1.05 PM : Topic: Four Factor Prothombin complex concentrate

Speaker: Dr. Mallikarjun

1.05- 1.25 PM : Topic: Case Based discussion

Speaker: Dr. Nilesh Wasekar

Pannelists: Dr. M B Agrawal, Dr. Tulika Seth, Dr. Nita Radhakrishnan, Dr. Mallikarjun

Sponsored Symposium-3

By Roche

Topic: Paradigm Shift In Hemophilia a Management

Context Setting: Dr. A K Tripathi

Topic: Redefine the management of Hemophilia A with Hemlibra

Speaker: Dr. Chandrakala

Panel Discussion : How can we achieve optimal drug management for al PwH A with or without Inhibitors

Moderator: Dr. Naresh Gupta

Panellists: Dr. Aby Abraham, Dr. Chandrakala, Dr. Kundan Mishra, Dr. S S Roy, Dr. Tulika Seth

Concluding Remarks: Dr. A K Tripathi

Sponsored Symposium-4

By Novartis

Topic: Challenges and unmet needs in the management of CML 3rd line and beyond.

Chairperson : Dr. Sharat Damodar

Topic: REACHing a new frontier with Ruxolitinib in GvHD management.

Speaker : Dr. Arijit Nag

Panel Discussion : Optimizing SR GvHD Management with Ruxolitinib - Experts : TBD

1.25-2.00 PM

Lunch Break with Poster Walk

2.00-3.00 PM

Oral abstract session - 1

Chairpersons: -Dr. Upasana Mukherjee & Dr. Basu Nandita

Judges: -Dr. Tulika Seth & Dr. Kaushik Paul

Oral abstract sessions - 2

Chairpersons: -Dr. Syed Hasan & Dr. Neha Singh

Judges: -Dr. Siyaram Didel & Dr. Monica Gupta

Oral abstract sessions - 3

Chairpersons: -Dr. Divya Bansal & Dr. Pranab Kumar Bhattacharyya

Judges: -Dr. Bhavana Dhingra & Dr. Indrani Roy Bagchi

Oral abstract sessions - 4

Chairpersons: -Dr. Jasdeep Singh & Dr. Malini Garg

Judges: -Dr. Mayur Parihar & Dr. Prakash Singh Shekhawat

2.00 PM - 2.12 PM

Role of granulocyte transfusions in hematopoietic stem cell transplantation: Experience from a tertiary care hospital in North India

Speaker: Dr. Sanjeev

Authorship diversity in haematology-related Cochrane systematic reviews: Inequities in global representation

Speaker: Dr. Arkadeep Dhali

Upfront combined hydroxyurea and imatinib versus imatinib monotherapy in newly diagnosed chronic phase chronic myeloid leukaemia patients with reference to early molecular response: A randomized controlled trial

Speaker: Dr. Rituparna Chetia

Standardization of digital droplet PCR (DDPCR) for T(8;21) RUNX1::RUNX1T1 MRD monitoring in acute myeloid leukemia

Speaker: Dr. Poonam Das

2.13 PM - 2.24 PM

Quinolone prophylaxis and carbapenem-resistant infection in patients undergoing hematopoietic stem cell transplant

Speaker: Dr. Rahul Naithani

Automation vs. manual platelet count- An audit of a real-life scenario in a tertiary care centre in India

Speaker: Dr. Ankita Dewangan

Validation of ELN 2022 risk stratification system for acute myeloid leukemia patients- In comparison with ELN 2017 from a tertiary care centre

Speaker: Dr. Ramesh Balasubramanian

Clinical utility of CD177 in the diagnosis of myelodysplastic syndrome

Speaker: Dr. Denna Sarah Prabhin

2.25 PM - 2.36 PM

Role of microRNA in hydroxyurea mediated HBF induction in sickle cell anaemia patients

Speaker: Dr. Neha Kargutkar

Exploring the alterations in erythrocytes and haemoglobin in women with PCOS: A follow up study

Speaker: Dr. Ipsita Chakraborty

Randomised controlled study to compare toxicity profile of dexamethasone versus prednisolone in induction phase chemotherapy in pediatric & adolescent ALL

Speaker: Dr. Karthik Kumar

Correlation between flow cytometric expression of CRLF2 and FISH rearrangement of CRLF2: A study of 30 cases from tertiary cancer centre in North East

Speaker: Dr. Karthik R

2.37 PM - 2.48 PM

Experience of ITI therapy for hemophilia patients from a tertiary care center of Eastern India: A one-year follow up

Speaker: Dr. Prerna Pramanik

Reticulocyte haemoglobin equivalent as a potential marker for diagnosis and treatment response of iron deficiency anaemia

Speaker: Dr. Manali Satiza

Indian multicenter phase II randomised controlled study comparing post stem cell maintenance regimen for newly diagnosed multiple myeloma (Impose bortecon study)

Speaker: Dr. Uday Yanamandra

Prospective analysis of the genomic landscape of ‘B-other ALL’ and its impact on clinical outcome: Data from a single tertiary cancer care centre in India

Speaker: Dr. Purvi Mohanty

2.49 PM - 3.00 PM

Concizumab prophylaxis in patients with haemophilia A or B with inhibitors: Efficacy and safety results from the primary analysis of the phase 3 explorer7 trial

Speaker: Dr. Chetna Kaushik

Flow cytometric estimation of platelet derived microparticles isolated by sedimentation and centrifugation protocols in chronic diseases: A comparative study

Speaker: Dr. Shagun Wadhwa

Hodgkin lymphoma: Experience with PET guided de-escalation of therapy in real world

Speaker: Dr. Akshay Lahoti

Validation of NGS based RNA fusion sequencing in myeloid neoplasm: A single center experience.

Speaker: Dr. Kallol Saha

3.00-4.15 PM

Session 27 - Aplastic anaemia

Chairperson: Dr. Naveen Gupta & Dr. Samira Kumar Behera

Session 28 - Consultative Haematology-1

Chairperson: Dr.Udas Ghosh & Dr. Kalidas Biswas

Session 29 - Bleeding disorders

Chairperson: Dr. Uday Yanamandra & Dr. Kalpana Dutta

Session 30 - Stem Cell Transplant

Chairperson: Dr. Ashish Dixit & Dr. Gautam Bhagwat

3.00-3.25 PM

Fanconi Anaemia: Diagnostic modalities.

Speaker: Dr. Mayur Parihar

Abnormal blood counts: Is the patient fit for surgery?

Speaker: Dr. Vijay Kumar

Quality control in the coagulation lab.

Speaker: Dr. Ankur Kumar Lath

Allogeneic SCT: The week after engraftment is vital.

Speaker: Dr. Nitin Gupta

3.25-3.50 PM

PNH clone Aplastic Anaemia: How to tackle.

Speaker: Dr. Saroj Bala

Thrombocytopenia in OPD: Etiology and counselling.

Speaker: Dr. Amrita Saraf

Approach to bleeding disorder in children.

Speaker: Dr. Seema Tyagi

Role of Haplotransplant in severe AA.

Speaker: Dr. Ganesh Jaishetwar

3.50-4.15 PM

AA: Current Concepts in Marrow Failure Syndromes

Speaker: Dr. Phillip Scheinberg

Management of liver disease-related bleeding.

Speaker: Dr. Avinash Pophali

Rare bleeding disorders: Case based discussions.

Speaker: Dr. Chandrakala Shanmukhaiah

Transplant in non-malignant disorder.

Speaker: Dr. Kundan Mishra

4.15-4.45 PM

Tea Break with Poster walk

4.45-6.00 PM

Session 31 - MDS

Chairperson: Dr. A. K. Ganju & Dr. Anjali Bandyapadhyay

Session 32 - Haemostasis in women

Chairperson: Dr. Kanchan Mukherjee & Dr. Meganathan Kannan

Session 33 - Hodgkin’s Lymphoma

Chairperson: Dr. Vishnu Sharma & Dr. Rajkumari Banashree Devi

Session 34 - Immune causes of Thrombocytopenia

Chairperson: Dr. Riju Rani Deka & Dr. Garima Anandani

4.45-5.10 PM

Diagnostic evaluation in MDS: Is it all about molecular profiling?

Speaker: Dr. H.P.Pati

Heavy menstrual bleed in teens: Diagnostic challenges.

Speaker: Dr. Jasmina Ahluwalia

Role of FDG-PET in lymphoma.

Speaker: Dr. Aby Abraham

Testing for HIT.

Speaker: Dr. Swati Pai

5.10-5.35 PM

Childhood MDS: Where are we now?

Speaker: Dr. Deepak Bansal

Thrombotic microangiopathy in pregnancy: Is it different?

Speaker: Dr. Avinash K.Singh

Relapsed/refractory HL: Therapeutic options in 2022.

Speaker: Dr. Shuvra Neel Baul

Treatment of HIT.

Speaker: Dr. Suman Pramanik

5.35-6.00 PM

Treatment of Low Risk MDS in 2022.

Speaker: Dr. Chepsy. C. Philip

Anticoagulation in pregnancy.

Speaker: Dr. Naresh Gupta

Follow up of patients with HL.

Speaker: Dr. Sharat Damodar

Management of ITP in adults.

Speaker: Dr. Vinay V Bohara

6.00 PM Onwards

( Inauguration Ceremony - Biswa Bangla Convention Center ) and
Cultural Program with Dinner at : Wet O Wild-NICCO PARK ,Street Number 27, Salt Lake Bypass, Sector IV, Kolkata, West Bengal 700106

5thNOVEMBER 2022, Saturday


Hall A

Hall B

Hall C

Hall D

7.00 AM

Walk for Haematology

7.30 AM onwards


8.00-8.30 AM


8.30-9.00 AM

Session 35 - Dr. Malti Sathe Oration(Hall A)

Chairpersons: Dr. P. K. Gogoi & Dr. Kanjaksha Ghosh

Topic-"Providing molecular diagnostic services for nonmalignant hematological diseases: Trials, tribulations, and satisfactions "

Speaker: Dr. Reena Das

9.00 - 10.15 AM

Session 36 - Acute Myeloid Leukemia

Chairpersons: Dr.Sajad Ahmed Geelani & Dr. AMVR Narendra

Session 37 - Thalassemia

Chairpersons: Dr. Bisnu Prasad Dash & Dr Vishrut KS

Session 38 - ALL in older patients

Chairperson: P.P.Gupta & Dr. Farah Jijina

Session 39 - Transfusion Therapy

Chairperson: Dr. Biplabendu Talukder & Dr. Sisir Patra

9.00 - 9.25 AM

Treatment of unfit AML: approvals and ongoing trials

Speaker: Dr. Aniket Bankar

Capillary Electrophoresis: Hope for diagnosis in thalassemia.

Speaker: Dr. Basab Bagchi

Molecular genetics of B cell ALL

Speaker: Dr. Sanjeev K.Gupta

Erythrocyte Alloimmunisation: How to overcome?

Speaker: Dr. Prasun Bhattacharyya

9.25 - 9.50 AM

AML Post (3+7): How to guide the patient and family through the ordeal of further therapy.

Speaker: Dr. Sukanya Gogoi

Thalassemia: Alternatives to blood transfusion.

Speaker: Dr. Baba Inusa

Treatment of the older adult with ALL : Personalized therapy.

Speaker: Dr. Samar Kulkarni

Chronic transfusion therapy in bone marrow failure: Personalized approach.

Speaker: Dr. Soumya Bhattacharya

9.50 - 10.15 AM

Targeted relapse refractory AML.

Speaker: Dr. Gautam Borthakur

Prenatal diagnosis of thalassemia

Speaker: Dr. Anita Nadkarni

How to treat relapsed ALL in older patients?

Speaker: Dr. Pravas Mishra

Management of Haemolytic transfusion reactions.

Speaker: Dr. Anshul Gupta

10.15-10.45 AM

Coffee Break

10.45-12.15 PM

Session 40 - ISHBT-EHA Joint Symposium(Hall A)

Chairpersons: Dr. Shanaz Khodaiji & Dr. Konstanze Dohner

Topic: Acute Myeloid Leukemia

Topic: Towards precision medicine in AML Speaker : Dr. Konstanze Dohner

Topic: Treatment of IDH mutated AML Speaker : Dr. Stephane de Botton

Topic: AML-Challenges in Indian Context Speaker : Dr. Vikram Mathews

12.15-1.00 PM

Sponsored Symposium - 5

By Intas Pharmaceuticals Ltd.

Topic: Role of Romiplostim in Severe Aplastic Anemia

Speaker: Dr. Ganesh Jaishetwar

Topic: Case Based Panel Discussion

Moderator: Dr. Sameer Tulpule

Pannelists: Dr Nishad Dhakate,Dr Saurabh Bhave, Dr Anupam Chakrapani, Dr Seema Bhatwadekar, Dr Mahesh Rajashekaraiah, Dr Santanu Sen, Dr Soumya Bhattacharya, Dr Arun V, Dr. Manas Kalra

Sponsored Symposium - 6

By AstraZeneca

12.15 - 12.45 PM : Topic: Expert discussion on management of HR CLL with Calquence

Speaker & Moderator : Dr. Rahul Naithani

Panelist : Dr Pawan Kumar Singh, Dr Shilpa Bhartia, Dr Kundan Mishra, Dr Sanjeev, Dr Sudeep V, Dr Anshul Gupta

Session 2

12.50 - 1.20 PM : Topic: Management of CLL in 2022 with newer generation BTK inhibitors

Speaker : Dr. Saurabh Bhave

Sponsored Symposium - 7

By Novonordisk

Welcome remarks

Speaker: Dr S Pramanik

Novo Nordisk

Topic: commitment to Rare Blood Disorders

Speaker: Dr. Rinz Paulose

Topic: Changing landscape of haemophilia with EHL factors: unmet needs and guidelines

Speaker: Dr. Sonali Salve

Topic: Driving change with glycopegylated EHL factors: clinical data and real-world experiences in India

Speaker: Dr. Tulika Seth

Closing remarks: Dr S Pramanik

Sponsored Symposium - 8

By Horiba

Topic: Evolving paradigm of hemocytomorphometry- from cell counts to morphology!

Speaker: Dr. Anil Handoo

1.00-2.00 PM

Lunch Break

2.00-3.00 PM

Oral abstract sessions - 5

Chairpersons: -Dr. Tribikram Panda & Dr. Tara Roshni Paul

Judges: -Dr. Abhishek Sharma & Dr. S. P. Verma

Oral abstract sessions - 6

Chairpersons: -Dr. Narendra Agrawal & Dr Praveen Sharma

Judges: -Dr Rajib Mondal & Dr. Suman Ghosh

Oral abstract sessions - 7

Chairpersons: -Dr. Anita Chopra & Dr. Gurpreet Kaur Sagoo

Judges: -Dr. Emine A Rahiman & Dr. Tanvi Gupta

Oral abstract sessions - 8

Chairpersons: -Dr. Sambit K Samanta & Dr. Rajiv Kumar

Judges: -Dr Tamal Kanti Ghosh & Dr. Rishi Dhawan

2.00 PM - 2.12 PM

Modulating effects of alpha globin gene mutations in defining the phenotypes of IVS1-5(CC) beta thalassemia patients

Speaker: Dr. Jyoti Shaw

Comparative study of cellular morphology of bone marrow aspiration, bone marrow imprint smear, and bone marrow biopsy in tertiary care centre

Speaker: Dr. Priti Toppo

Whole exome mutation study in triple negative polycythemia- An Indian quest

Speaker: Dr. Harikrishnan P

Unravelling the somatic mutational landscape in myelodysplastic syndrome: A single center experience

Speaker: Dr. Indranil Dey

2.13 PM - 2.24 PM

A limited and economical genotyping panel unravels the molecular genetic basis of beta-thalassemia intermedia in a majority of cases: A study on 256 Indian patients

Speaker: Dr. Namrata Singh

HLA matching profile among transplant eligible patients in Indian scenario

Speaker: Dr. Surbhi Saxena

Study of BCR-ABL1 kinase domain mutation profile: A 10 years experience of a tertiary cancer care center

Speaker: Dr. Debajani Nathi

Mono-Dysplasia score based on automated cell counters- A novel parameter for differentiating reactive monocytosis form haematological malignancies

Speaker: Dr. Priyanka Moule

2.25 PM - 2.36 PM

Clinical profile and impact of viral infections (CMV, EBV & Parvovirus) on pediatric hematoncology patients

Speaker: Dr. Purvaja Kubde

Differentiation of aplastic anaemia from myelodysplastic syndrome using cell population data analysis on SYSMEX XN-9000 automated hematology analyser

Speaker: Dr. Sreya P B

Long-term real-world outcomes of patients with high-risk acute promyelocytic leukemia treated with arsenic trioxide and all trans retinoic acid without chemotherapy

Speaker: Dr. Charanpreet Singh

Clinicopathological and immunophenotypic characteristics of hairy cell leukemia: An institutional experience

Speaker: Dr. Somanath Padhi

2.37 PM - 2.48 PM

Clinical outcomes of allogeneic stem cell transplantation in adolescents and young adults with thalassemia major: A single centre experience.

Speaker: Dr. Mithun Prakash

Sigma metrics in haematology: Are second party controls a better alternative?

Speaker: Dr. Khevna Kansara

Feasibility and safety of using gemtuzumab ozogamicin in the treatment of acute myeloid leukemia: Real world data from a tertiary care cancer center in India

Speaker: Dr. Vinay Anand Guntiboina

Myeloid-derived suppressor cells: A silent foe in precursor B cell acute lymphoblastic leukemia

Speaker: Dr. Mousumi Kar

2.49 PM - 3.00 PM

Assessment of liver fibrosis by fibroscan as a surrogate marker in beta thalassemia major patients.

Speaker: Dr. Sukanya Priyadarshini Mohanty

Performance evaluation of digital cell imaging by SYSMEX DI-60 integrated into automated hematology analyzer system

Speaker: Dr. Debirupa De

Diagnostic Splenectomy: Clinical profile, role and relevance in diagnosis of lymphoma

Speaker: Dr. Nutan Joshi

Study of association between CRLF2 overexpression and post induction MRD status by flow cytometric evaluation in PH-like B-ALL patients.

Speaker: Dr. Vineeta Yadav

3.00-4.15 PM

Session 41 - Sickle Cell Disease

Chairperson: Dr. Mohandas Narla,Dr. Magaret C & Dr. Reena Mittal

Session 42 - Chronic Lymphocytic Leukemia

Chairperson: Dr. Sailendra Prasad Verma & Dr. Anjali Kelkar

Session 43 - Secondary Leukemia

Chairperson: Dr. Sudipto Roy & Dr. Joydeep Chakraborty

Session 44 - Hemophagocytic Lymphohistiocytosis

Chairperson: Dr. Prabhu Manivannan & Dr. Narender Kumar

3:00 - 3:25 PM

Transforming SCD Care in India: Catalyst for Advancing Initiatives in Africa.

Speaker: Dr. Isacc Odame

Risk stratification in CLL.

Speaker: Dr. Shanaz Khodaiji

Genetics of progression from MDS to secondary leukemia.

Speaker: Dr. Neeraj Arora

HLH during initial evaluation: How important is genetics?

Speaker: Dr. Debdatta Basu

3:25 - 3:50 PM

Sickle Cell Pain: Working Towards the Challenge

Speaker: Dr. Kalpana Gupta

Treatment strategies in CLL : Current and future.

Speaker: Dr. Sumit Mitra

MPN transformation to acute leukemia: How to tackle?

Speaker: Dr. Farah Jijina

HLH: Overview of initial management and monitoring.

Speaker: Dr. Uttam Kumar Nath

3:50 - 4:15

Iron metabolism in thalassemia and SCD.

Speaker: Dr. Maitreyee Bhattacharyya

Toxicities of targeted therapies in CLL : How to manage?

Speaker: Dr. Rahul Naithani

ALL after antecedent malignancy: What exactly do we know?

Speaker: Dr. Anupam Chakrapani

HLH: How to treat relapse or refractory disease?

Speaker: Dr. Fouzia

4.15-4.45 PM

Tea Break + Poster walk

4.45-5.45 PM

Session 45 - AML 2

Chairperson: Dr. Smita Das & Dr. Asish Rath

Session 46 - Plasma Cell Disorders

Chairperson: Dr. Madhuchanda Kar & Dr. Ankit Kumar

Session 47 - Aggressive lymphomas

Chairperson: Dr. Shazia Gulshan & Dr. Tarun Chaudhury

Session 48 - Anaemias

Chairperson: Dr. Sudhir Kumar Atri & Dr. Debdas Bose

4:45 - 5:05 PM

AML diagnosis: Is there still a role of morphology and cytochemistry in the era of IPT?

Speaker: Dr. Tejindar Singh

MM: Moving beyond proteosome inhibitors in India.

Speaker: Dr. Pankaj Malhotra

NHL in children: How are they different from those in adults?

Speaker: Dr. Jina Bhattacharyya

Acquired PRCA: Evaluation and treatment

Speaker: Dr. Bhushan Asthana

5:05 - 5:25 PM

Treatment approaches and monitoring of patients of APML.

Speaker: Dr. Prasanth Ganesan

Therapy in AL amyloidosis: Newer options.

Speaker: Dr. Shaji Kumar

Aggressive B cell lymphoma in the elderly: Approach to therapy.

Speaker: Dr. Gaurav Dixit

Anaemia of cancer: How to treat?

Speaker: Dr. Sanjeevan Sharma

5:25 - 5:45 PM

Older patients of AML-How to treat?

Speaker: Dr. Sandeep Saha

Smouldering myeloma: Do we need to treat?

Speaker: Dr. Rajesh Kashyap

Relapsed or refractory lymphomas in the elderly: What should be the goals of care.

Speaker: Dr. Dipanjan Halder

Approach to nutritional anemia.

Speaker: Dr. P.K.Sasidharan

5.45-6.45 PM

Sponsored Symposium - 9

By Roche

Topic : Introduction & Context Setting

Speaker: Dr. Javid Rasool Bhat

Modem Perspectives : Choosing optimal treatment strategy for management of Follicular Lymphoma in 2022,

Case based Discussion

Moderator: Dr. Rahul Naithani

Panellists: Col (Dr) Suman Pramanik,Dr Nataraj KS, Dr Sreeraj Vasudevan,Dr Ganesh Jaishetwar,Dr Nishad Dhakate

Concluding remarks

Speaker: Dr Javid Rasool Bhat

Sponsored Symposium - 10

Astellas Pharmaceuticals

Topic: Epidemiology and Management Paradigm for FLT3+ Acute Myeloid Leukemia

5.45-5.50 PM : Welcome Note-Astellas Medical Team

5.50-5.55 PM : Setting the context-Dr M.B. Agarwal (Chairperson)

5.55-6.15 PM : Epidemiology and diagnostic paradigm for FLT3+ Acute Myeloid Leukemia

Speaker: Dr. Arijit Nag

6.15-6.35 PM : Management Paradigm for FLT3+ Acute Myeloid Leukemia

Speaker: Dr. Anupam Chakrapani

6.35-6.45 PM : Discussion + Q & A

Sponsored Symposium - 11

By Pfizer

Topic : Diagnosis and Prognosis of Haemophilia

Speaker: Dr. Jina Bhattacharya

Topic : Recent Updates in treatment of Relapsed or refractory B cell Adult Acute Lymphoblastic Leukemia

Speaker: Dr. Soumya Mukherjee

Sponsored Symposium - 12

By Sebia

Topic : Capillary Electrophoresis : An advanced Technology for the Screening of Hemoglobinopathies & Thalassemia

Welcome Note : Dr. Mandeep Singh

Topic : Evolution of different technologies

Speaker : Dr. Siddhartha Sharma

Topic : Landscaping of Hemoglobinopathies through CE technology

Speaker : Dr. Arpita Roy Dam

Topic : Instrument Demonstration

Speaker : Dr. Divya Jain

User experience & Quiz


Tea Break

7.00-8.00 PM

General Body Meeting

8.00 PM Onwards

Gala Dinner at : Cafe Ekante-Eco Park, Eco Island, Ekante, New Town, West Bengal 700156

6th NOVEMBER 2022, Sunday


Hall A

Hall B

Hall C

Hall D

8.00-9.30 AM


9.30-11.00 AM

Session 49 - Dr. J C Patel Award Session (Hall A)

Chairpersons: Dr. Utpal Choudhuri and Dr. Pradip Mitra

Judges: Dr. Amar Dasgupta, Dr. Vikram Mathews, Dr. Kanjaksha Ghosh, Dr. Tulika Seth & Dr. Mayur Parihar

Cytomegalovirus reactivation as a risk factor for all-cause mortality in children undergoing hematopoietic stem cell transplantation:experience over two decades from a tertiary referral center in India.

Speaker : Dr. Sohini Chakraborty

Genetic Spectrum of common and rare inherited bleeding disorders in North India: Next generation sequencing-based approach.

Speaker : Dr. Ritika Sharma

Therapy acquired clonal mutations drive a significant subset of early relapses in pediatric B-cell precursor acute lymphoblastic leukemia cases.

Speaker : Dr. Rozy Thakur

Infrared thermography- a point of care tool for detection of subclinical bleed in patients with haemophilia on propylaxis.

Speaker : Dr. Moupali Ghosh

Venetoclax induces autophagy and apoptosis by targeting Stat3/Bcl-2 axis in arsenic trioxide resistant acute promyelocytic leukemia.

Speaker : Dr. Deepshikha Dutta

11.00-11.15 AM

Tea Break

11.15-12.30 PM

Session 50 - Interesting case Based Learning (Laboratory-15 mins Each )

Chairpersons: Dr. Nilesh Wasekar & Dr. Priyanka Mishra

• Haemolytic anaemia.

Speaker: Dr. Jasashwi Chakraborty

• Myeloproliferative Neoplasm

Speaker: Dr. Sabina Langer

• Myelodysplastic Syndrome

Speaker: Dr. Jitendra Mohan Khungar


Speaker: Dr. Rakhee kar

Session 51 - Interesting case Based Learning (Clinical-15 mins Each)

Chairpersons: Dr. Kumar Saurabh & Dr Pulkit Rastogi

• Inherited bone marrow failure.

Speaker: Dr. Sudha Sethy

• HSCT complications

Speaker: Dr. Rajib De

• Immune thrombocytopenia

Speaker: Dr. Subhash Chandra Jha

• Acute Myeloid Leukemia

Speaker: Dr. Uday Prakash Kulkarni


Session 52 - Consultative Haematology-2

Chairperson: Dr. Asim Mallik & Dr. Pradeep Kumar V

Session 53 - Consultative Haemotology-3

Chairperson: Dr. Gaurav Dinghra & Dr. Ganesh Kumar V

Management of Eosinophilia beyond steroids.

Speaker: Dr. Saurav Bhave

Thrombocytosis in OPD setting

Speaker: Dr. Seema Bhatwadekar

Bleeding in neonates.

Speaker: Dr. Pritam Singha Roy

Role of Haematologist during liver transplant.

Speaker:Dr. Abhishek Sharma

Bleeding in the Uremic patients.

Speaker: Dr. Shuvra Neel Baul

Haematological abnormalities in parasitic infections in our country.

Speaker: Dr. Jyoti Kotwal

12.30-1.40 PM

Session 54 - Bench to bed side

Chairpersons: Dr. Pranati Mohanty & Dr. Subham Bhattacharyya

Session 55 - Debate

Chairpersons: Dr. Soumya Mukherjee & Dr. Shazia Gulshan

Session 56 - Consultative Haematology - 4

Chairpersons: Dr. Arnab Chattopadhyay & Dr. Jeevan Kumar Garg

Session 57 - Plasma cell Neoplasm

Chairpersons: Dr. Pallavi Bhuyan & Dr. Karthik Bommannan

• Thrombosis in high altitude

Speaker: Dr Velu Nair

• Pharmacological correction of G6PD for the management of hemolytic anemia

Speaker: Dr. Shailja Singh

• Advanced diagnostic tools for congenital hemolytic anemia (CHA): New concepts and strategies.

Speaker: Dr. Prabhakar Kedar

12.30 - 1.05 PM
Debate 1 - (15mins +15 mins +5 mins)

Laboratory haematology should be an integral part of Haematology Department

Yes: Dr.Arijit Nag

No: Dr. Siddhesh Kalantri

1.05 - 1.40 PM
Debate 2 - (15mins +15 mins +5 mins)

We cannot do without stem cell transplant in Mantle cell lymphoma

Yes: Dr. Rahul Bhargava

No: Dr. Prantar Chakrabarti

• Abnormal coagulation parameters in the ICU setting

Speaker: Dr. Pankhi Dutta

• Fungal infection in haematological malignancy.

Speaker: Dr. Sonali Mohapatra

• CML in pregnancy.

Speaker: Dr. Sarmila Chandra

Monoclonal gammopathies of clinical significance

Speaker: Dr. Ashutosh Wechalekar

Elderly Myeloma –How to approach?

Speaker: Dr Mukul Agarwal

POEMS-Where we are in 2022?

Speaker: Dr. Sanjeev

1.40 PM Onwards